Services

28 févr.: L´OREAL : EPISKIN, FILIALE DE L´OREAL, ACQUIERT SKINETHIC, LEADER..
28 févr.: UBISOFT ENTERTAINMENT : Nouveaux gains de parts de marché en janv..
28/02/2006 18:13:00

L´OREAL : EPISKIN, SUBSIDIARY OF L´OREAL, ACQUIRES SKINETHIC, LEADER IN TISSUE ENGINEERING

Related content
16 nov. - 
L'OREAL : Déclaration du nombre total de droits de vote..
03 nov. - 
L'Oréal : Communiqué : « Chiffre d'affaires au 30 septe..
05 oct. - 
L'OREAL : Déclaration du nombre total de droits de vote..

Alternative Approaches to Safety Evaluation:"a top Priority for L´Oréal"

Episkin, subsidiary of L´Oréal, acquires SkinEthic, leader in Tissue Engineering

- Acquisition of SkinEthic Places L´Oréal in the front line of Technologies

Dedicated to Research and Safety Evaluation - Clichy 28th February, 2006 - L´Oréal has today underlined its commitment to the further development of alternative methods for safety evaluation with the announcement that Episkin, a subsidiary of the group that is dedicated to the development of reconstructed skin, has acquired SkinEthic. SkinEthic, based in Nice, France, is expert in the field of tissue engineering, and its know-how will complement and widen the expertise that already exists within L´Oréal.

SkinEthic is an important worldwide player in the production and commercialisation of human epidermal and epithelial tissues (including epidermis, dermis, corneal, oral, gingival, oesophageal epithelium, alveolar and vaginal mucosa) for in vitro test applications across many industries.

L´Oréal´s ultimate goal is to develop a range of approaches and standardised in vitro methods that can be used to test ingredient safety and shared across a number of industry sectors; with the aim of accelerating the elimination of animal testing. The complimentary nature of Episkin and SkinEthic allows L´Oréal to further advance its commitment to the development of alternative methods for the safety assessment of product ingredients.

Commenting on the acquisition, Jean-François Grollier, Vice-President of Research and Development at L´Oréal said "Providing cutting-edge teams, such as these, with the opportunity to work at the crossroads of science and industry, demonstrates our support for sustainable innovation."

"The acquisition of SkinEthic allows us to respond to the needs of the entire industry and more specifically in the area of alternative approaches to animal testing - a top priority for L´Oréal", he continued.

"The acquisition provides SkinEthic with a new approach to the market and brings with it the research capability that will benefit all present and future customers", added Doctor Martin Rosdy, founder of SkinEthic.

L´Oréal supports the objective of the elimination of laboratory animal testing and is working on various alternative methods that must be validated by competent scientific authorities.

L´Oréal has been committed to the development of alternative approaches for more than twenty years and has already contributed to successful scientific validations together with ECVAM (European Centre for Validation of Alternative Methods). The company has not carried out or commissioned tests of products on animals since 1989.

"This news release does not constitute an offer to sell, or a solicitation of an offer to buy, L´Oréal shares. If you wish to obtain more comprehensive information about L´Oréal, please refer to the public documents registered in France with the Autorité des Marchés Financiers [which are also available in English on our Internet site: www.loreal-finance.com].

This news release may contain some forward-looking statements. Although the Company considers that these statements are based on reasonable hypotheses at the date of publication of this release, they are by their nature subject to risks and uncertainties which could cause actual results to differ materially from those indicated or projected in these statements."

Contacts at L´Oréal :

Individual Shareholders and market authorities

Mr. Jean-Régis CAROF

Phone. : 00.33.1.47.56.83.02

Fax : 00.33.1.47.56.86.42

http://www.loreal-finance.com

Analysts and institutional investors

Mrs Caroline MILLOT

Phone : 00.33.1.47.56.86.82

Fax : 00.33.1.47.56.42.02

Journalists

Mr. Lorrain KRESSMANN

Phone : 00.33.1.47.56.40.24

http://www.loreal.com

Standard

Phone : 00.33.1.47.56.70 00

Le communiqué dans son intégralité est disponible sur http://www.companynewsgroup.com

© CompanynewsGroup

28 févr.: L´OREAL : EPISKIN, FILIALE DE L´OREAL, ACQUIERT SKINETHIC, LEADER..
28 févr.: UBISOFT ENTERTAINMENT : Nouveaux gains de parts de marché en janv..

Envoyer un commentaire

Related debate

  • 1 semaine
  • 1 mois
  • 1 an
Ingen indlæg

Actualité la plus lue

  • 24 heures
  • 48 heures
  • 1 semaine
1
CREDIT AGRICOLE SA : DECLARATION DES DROITS DE VOTE NOVEMBRE 2016
2
Maroc Telecom : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social_Novembre 2016
3
Avec giropay, les marchands, Marketplaces et PSPs connectés à Limonetik disposent d'un accès direct à 35 millions de consommateurs Allemands
4
HF Company : Information relative au nombre total de droits de vote et d'actions ... - nov 2016
5
Gain de productivité et d'espace : Touax Solutions Modulaires passe progressivement de l'externalisation à la dématérialisation de ses factures clients avec Esker

Related stock quotes

L'OREAL 159,10 0,0% Cours de bourse inchangé

Buy and sell signals

  • Tendance
  • Moneymachine
Acheter
Vendre
Acheter

Droit d'auteur Euroinvestor A/S 2016   Mentions légales et conditions d'utilisation
Information sur les cours fournies par Interactive Data.
Les données sont différées de 15 à 20 minutes selon les accords avec les différentes bourses internationales.
 
mardi 6 décembre 2016 06:42:33
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20161205.1 - EUROWEB3 - 2016-12-06 06:42:33 - 2016-12-06 06:42:33 - 4 - Website: OKAY